Innocare Optoelectronics vs Abbott Laboratories: Fair Value & Quality
Both stocks run through our valuation models. Here is how Innocare Optoelectronics (6861) and Abbott Laboratories (ABT) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Innocare Optoelectronics trades at TWD 221 versus a fair value of TWD 73.09 (-67%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Innocare Optoelectronics
6861.TW · TWD · Health Care
-67%
upside to fair value
overvalued
PriceTWD 221
Fair ValueTWD 73.09
Quality63/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Innocare OptoelectronicsAbbott Laboratories
Valuation
55.7×P/E (TTM)27.7×
3.45×P/S (TTM)3.89×
6.03×P/B3.36×
30.5×EV/EBITDA15.1×
—PEG1.47×
0.9%Dividend yield—
TWD 2.00Dividend per share—
Profitability
8%Net margin14%
11%Operating margin13%
14%Return on equity12%
5%Return on assets6%
Growth
47%Revenue growth (YoY)8%
6.7%Avg. growth/yr (3Y)0.5%
-0.4%Avg. growth/yr (5Y)5.1%
Balance & size
—Debt / equity0.19×
$273MMarket cap$175B
weakGrowth qualityhealthy
Abbott Laboratories leads: 4 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Innocare Optoelectronicsof which business quality 66 · market factors 48Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
47
50
Quality GrowthAre margins and returns improving?
44
47
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
52
65
Low VolatilityCalm price path (market factor)
0
83
MomentumPrice trend over the last 3–12 months (market factor)
67
40
52W MomentumDistance to the 52-week high (market factor)
70
33
Net IssuanceBuybacks instead of dilution
76
84
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Innocare Optoelectronics
DCF ModelsTWD 134
Earnings-BasedTWD 57.59
Dividend DiscountTWD 29.32
MultiplesTWD 70.77
Asset-BasedTWD 23.45
Growth DCFTWD 129
Economic ProfitTWD 46.49
Growth EarningsTWD 88.80
26 of 26 models see the stock below the current price.
Abbott Laboratories
DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Innocare Optoelectronics
Bear TWD 59.23Fair Value TWD 73.09Bull TWD 86.96
TWD 221 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Innocare Optoelectronics · Health Care
Quality score63 · above median
Fair value upside-67% · bottom 25%
Abbott Laboratories · Health Care
Quality score67 · Top 25%
Fair value upside-31% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Innocare Optoelectronics trades at TWD 221 versus a fair value of TWD 73.09 (-67%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Abbott Laboratories has the higher quality score (67/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
